- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07500142
Evaluation of the Group Problem Management Plus (Group PM+) Pilot Study in Oromia and Amhara Regional States, Ethiopia
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Addis Ababa, Ethiopia
- Rural communities
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- have signs and symptoms of depression or dysfunction as measured by the PHQ-9 and WHODAS 2;
- be between 18 and 59 years old,
- be the main decision-maker or spouse of the main decisionmaker.
Exclusion Criteria:
- individuals with signs of severe depression or suicide
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Does not receive any intervention
|
|
|
Experimental: gPM+
Receives gPM+ therapy sessions
|
Problem Management Plus (PM+) is an intervention developed by WHO in 2013 to address common mental health problems such as depression, stress, and anxiety.
It involves problem management (PM) plus (+) selected behavioral strategies to address both psychological issues (e.g., stress, fear, feelings of helplessness) and practical problems (e.g., livelihood problems, conflict in the family) (World Health Organization 2016).
It was conceived initially as individual counselling composed of 5 sessions.
In villages randomized to the gPM+ treatment, same-sex therapy groups of 3 to 8 individuals will be formed and facilitated by Community Health Facilitators (CHF) for women and Men's Group Facilitators (MGF) for men.
|
|
Experimental: Cash
Receives cash transfer
|
Eligible households in villages randomized to the Cash treatment will also receive a one-time lump sum transfer worth the equivalent value in Birr of $300 USD.
While the transfer is unconditional, it will be presented as a 'livelihoods transfer' to support income-generating activities that improve livelihoods.
|
|
Experimental: gPM+ and Cash
Receives gPM+ and cash
|
Problem Management Plus (PM+) is an intervention developed by WHO in 2013 to address common mental health problems such as depression, stress, and anxiety.
It involves problem management (PM) plus (+) selected behavioral strategies to address both psychological issues (e.g., stress, fear, feelings of helplessness) and practical problems (e.g., livelihood problems, conflict in the family) (World Health Organization 2016).
It was conceived initially as individual counselling composed of 5 sessions.
In villages randomized to the gPM+ treatment, same-sex therapy groups of 3 to 8 individuals will be formed and facilitated by Community Health Facilitators (CHF) for women and Men's Group Facilitators (MGF) for men.
Eligible households in villages randomized to the Cash treatment will also receive a one-time lump sum transfer worth the equivalent value in Birr of $300 USD.
While the transfer is unconditional, it will be presented as a 'livelihoods transfer' to support income-generating activities that improve livelihoods.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mental health index
Time Frame: We will collect data on indicators above immediately after the gPM+ sessions end (Oct 2022) and 12 months later (Oct 2023). We will assess outcomes at both time periods to see if impacts are sustained.
|
Mental health index will be composed of 5 mental health indicators listed below. To create the aggregate index, we standardize each indicator using the control mean and standard deviation. The aggregate indices are then simply the equally weighted average of the individual z-scores (Kling et al. 2007). The 5 indicators are:
As a robustness, we will also assess individual indicators that make up the summary index. |
We will collect data on indicators above immediately after the gPM+ sessions end (Oct 2022) and 12 months later (Oct 2023). We will assess outcomes at both time periods to see if impacts are sustained.
|
|
Economic index
Time Frame: 12 months after the gPM+ sessions end
|
Economic index will be composed of 4 indicators listed below. To create the aggregate index, we standardize each indicator using the control mean and standard deviation. The aggregate indices are then simply the equally weighted average of the individual z-scores (Kling et al. 2007). The 4 indicators are:
|
12 months after the gPM+ sessions end
|
|
Time use
Time Frame: We will collect data on indicators above immediately after the gPM+ sessions end (Oct 2022) and 12 months later (Oct 2023). We will assess outcomes at both time periods to see if impacts are sustained.
|
Time use index will be composed of 3 indicators listed below. To create the aggregate index, we standardize each indicator using the control mean and standard deviation. The aggregate indices are then simply the equally weighted average of the individual z-scores (Kling et al. 2007). The 3 indicators that will be used to construct the aggregate time use index are:
As a robustness, we will also assess individual indicators that make up the summary index. |
We will collect data on indicators above immediately after the gPM+ sessions end (Oct 2022) and 12 months later (Oct 2023). We will assess outcomes at both time periods to see if impacts are sustained.
|
|
Childcare
Time Frame: We will collect data on indicators above immediately after the gPM+ sessions end (Oct 2022) and 12 months later (Oct 2023). We will assess outcomes at both time periods to see if impacts are sustained.
|
Childcare index will be composed of 3 indicators listed below. To create the aggregate index, we standardize each indicator using the control mean and standard deviation. The aggregate indices are then simply the equally weighted average of the individual z-scores (Kling et al. 2007). The 3 indicators that will be used to construct the aggregate childcare index are:
As a robustness, we will also assess individual indicators that make up the summary index. |
We will collect data on indicators above immediately after the gPM+ sessions end (Oct 2022) and 12 months later (Oct 2023). We will assess outcomes at both time periods to see if impacts are sustained.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Khat consumption
Time Frame: Immediately after gPM+ session ends and 12 months later
|
Number of khat bundles consumed in a typical day
|
Immediately after gPM+ session ends and 12 months later
|
|
Tension reduction checklist
Time Frame: Immediately after gPM+ session ends and 12 months later
|
9-item checklist with response from 0 (not at all) to 4 (all the time).
Scores for each item will be summed leading to a total score that ranges from 0-36, with higher values indicating better outcomes.
|
Immediately after gPM+ session ends and 12 months later
|
|
Brief Cope (shortened to 6 items)
Time Frame: Immediately after gPM+ session ends and 12 months later
|
Coping Orientation to Problems Experienced Inventory (Brief -cope). We will recode questions so that higher values represent better coping strategy. We will then take the total score from the 6 questions. Scores will range from 6-24. |
Immediately after gPM+ session ends and 12 months later
|
|
Multi-dimensional Scale of Perceived Social Support
Time Frame: Immediately after gPM+ session ends and 12 months later
|
The Multidimensional Scale of Perceived Social Support (Zimet et al., 1988) is a 12-item measure of perceived adequacy of social support from three sources: family, friends, & significant other; using a 5-point Likert scale (0 = strongly disagree, 5 = strongly agree).
Scores will be summed across the 12 items, and thus range from 0-60, with higher scores indicating better social support
|
Immediately after gPM+ session ends and 12 months later
|
|
New general self-efficacy
Time Frame: Immediately after gPM+ session ends and 12 months later
|
New General Self-Efficacy Scale is an 8-item measure that assesses how much people believe they can achieve their goals, despite difficulties.
Using a 5-point rating scale (1= strongly disagree; 3 = neither agree nor disagree; 5 = strongly agree), respondents show how much they agree with eight statements, such as "Even when things are tough, I can perform quite well."
We will then calculate a total score by summing the response of each item.
Scores will then range from 8-40, with higher scores indicating more self efficacy.
|
Immediately after gPM+ session ends and 12 months later
|
|
Time and risk preference
Time Frame: Immediately after gPM+ session ends and 12 months later
|
From Global preference survey
|
Immediately after gPM+ session ends and 12 months later
|
|
Value of Investments in last 12 months
Time Frame: 12 months after gPM+ ended
|
Total value of investments will be assessed through a questionnaire that asks respondents how much they invested in livestock, farming, and non-agriculture activities in the last 12 months.
Responses will be totaled across activities.
|
12 months after gPM+ ended
|
|
Intimate Partner Violence (IPV)
Time Frame: 12 months after gPM+ ends
|
WHO violence against women instrument. Using this instrument we will create 3 binary indicators: No Emotional IPV: Binary variable =1 if respondent does not report any emotional violence from partner in the last 12 months No Physical IPV: Binary variable =1 if respondent does not report any physical violence from partner in the last 12 months No Sexual IPV: Binary variable =1 if respondent does not report any sexual violence from partner in the last 12 months |
12 months after gPM+ ends
|
|
Alcohol use (3 item)
Time Frame: Immediately after gPM+ session ends and 12 months later
|
The Alcohol Use Disorders Identification Test- we asked 3 items from the alcohol use disorders test.
We will take the total score that sums up the responses from the 3 items.
Total score will range from 0-12, with higher values indicating more alcohol use.
|
Immediately after gPM+ session ends and 12 months later
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Peptides
- Amino Acids, Peptides, and Proteins
- Proteins
- Intracellular Signaling Peptides and Proteins
- Apoptosis Regulatory Proteins
- Carrier Proteins
- Death Domain Receptor Signaling Adaptor Proteins
- Adaptor Proteins, Signal Transducing
- Tumor Necrosis Factor Receptor-Associated Peptides and Proteins
- CASP8 and FADD-Like Apoptosis Regulating Protein
Other Study ID Numbers
- InternationalIFPRI
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health Issue
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Stanford UniversityRecruitingMental Health IssueUnited States
-
The Hong Kong Polytechnic UniversityRecruiting
-
Yale UniversityEmpowerment to Heal - Uganda; Empower Through HealthRecruiting
-
The Hong Kong Polytechnic UniversityRecruiting
-
Hospices Civils de LyonCompleted
-
The Hong Kong Polytechnic UniversityCompleted
-
Limbic LimitedCompletedMental Health IssueUnited Kingdom
-
Babes-Bolyai UniversityThe Executive Agency for Higher Education, Research, Development and Innovation...Completed
-
Wake Forest University Health SciencesThe Duke EndowmentCompletedMental Health IssueUnited States
Clinical Trials on group Problem Management Plus
-
The New SchoolColumbia University; Universidad del Norte; HIASRecruitingMental Health Wellness 1Colombia
-
Children's National Research InstituteTravere Therapeutics, Inc.CompletedAnxiety | Depressive Symptoms | Post-traumatic Stress Disorder | Problems PsychosocialUnited States
-
International Islamic University, IslamabadAid To Leprosy Patients (ALP), Rawalpindi-PakistanCompletedPsychological Distress | Physical Condition, Minor Psychological ComponentPakistan
-
University of ZurichCompletedDepression | PTSD | Anxiety | Trauma | Distress | Functional Disabilities | Common Mental Health ProblemsSwitzerland
-
University of ZurichCompletedDepression | PTSD | Anxiety | Trauma | Distress | Functional Disabilities | Common Mental Health ProblemsSwitzerland
-
University of ZurichETH Zurich; The University of New South WalesRecruitingPTSD | Trauma | Psychological Distress | Common Mental Health ProblemsSwitzerland
-
University of ZurichETH Zurich; The University of New South WalesCompletedPTSD | Psychological Distress | Trauma, PsychologicalSwitzerland
-
George Washington UniversityTranscultural Psychosocial Organization NepalCompleted
-
The New SchoolGeorge Washington UniversityCompletedDepression | Anxiety Disorders | Psychological DistressUnited States
-
University of ChilePan American Health OrganizationCompletedDepressive Disorder | Anxiety DisordersChile